Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHA In Brief: Novoste Beta-Cath

This article was originally published in The Gray Sheet

Executive Summary

Novoste Beta-Cath: Results from pilot 35-patient study of beta-emitting catheter for restenosis show improved minimum lumen diameter after six months, Spencer King, MD, Emory University, reports at the American Heart Association annual conference in Orlando, Florida. "The majority of patients actually had a slight increase in their size," he noted. MLD was .75 mm prior to treatment, 2.07 mm post treatment and 2.1 mm at six months follow-up. Patients received 12 gy, 14 gy, or 16 gy of radiation. Enrollment in a 27-center, 1,110 patient study of the Beta-Cath is ongoing, King says. Novoste expects to submit a premarket approval application upon completion of the ongoing clinical trials...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009112

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel